Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A 28-year-old male is experiencing temple regrowth but crown thinning while using 5mg minoxidil and 0.5mg dutasteride. The shedding phase is seen as a positive sign of treatment effectiveness, with expectations of noticeable improvements around 6 to 12 months.

A user experienced hair shedding after switching to a generic finasteride brand, suspecting it might be a normal fluctuation at 6 months into treatment. Another user suggested that if the dosage is the same, the shedding is unlikely due to the brand change.

Using peppermint oil, rosemary oil, and minoxidil can lead to shedding, but hair regrowth is possible. Finasteride is also being used in the treatment.

Finasteride may be losing effectiveness for the user after 4.5 years, possibly due to intense workouts or a synchronized hair shedding cycle. Suggestions include switching to Dutasteride or continuing with Finasteride while considering a hair transplant for hairline density.

The user experiences increased hair loss in winter, possibly due to lack of sun and vitamin D, and is using finasteride and vitamin D3 supplements to address it. Suggestions include using a red light lamp and maintaining vitamin D intake.

A 28-year-old man experienced improved hair thickness and curliness after a year of using oral finasteride and minoxidil, despite initial shedding and stress. He also used Nutrafol for a few months and plans to discuss a hair shedding concern with his dermatologist.

The user experienced hair regrowth using dutasteride, finasteride, oral minoxidil, and ketoconazole, despite some setbacks. They are advised to focus on hair hydration and styling, as their hair loss is stable.

The user is experiencing a second hair shedding phase after 7 months on finasteride, oral minoxidil, and ketoconazole, and is concerned about the sustainability of the treatment. Others encourage continuing the treatment, explaining that shedding is normal and should stabilize over time.

A 19-year-old started losing hair in December 2023, tried minoxidil with initial success, but experienced further hair loss and added finasteride to the regimen. Users advised patience, explaining that shedding is common early in finasteride treatment and suggested continuing for at least a year for potential results.

Scalp tension from the occipitalis muscle is theorized to contribute to hair loss, but most believe DHT and genetics are the main causes. Treatments like finasteride and minoxidil are considered more effective than addressing scalp tension.

The user switched from finasteride to dutasteride for hair loss but faced increased shedding and anxiety, regretting not staying with finasteride longer. Other users shared mixed experiences, advising patience with dutasteride, as it may take up to a year to show results.

Switching from finasteride to dutasteride for treating hair loss, with reports of improved regrowth and little to no side effects.

PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.

Naepo's 5-month progress report detailing their journey of treating male pattern baldness with dutasteride and oral minoxidil, which has already resulted in an encouraging improvement in hair density. Others have responded with appreciation for the thorough report and asked further questions about Naepo's educational background.

Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.

Dr. Tsuji is giving online lectures about hair multiplication trials. Users express hope for a cure, but some are skeptical about its timeline.

The conversation is about using micro needling and PTD-DBM for hair loss treatment. The user applies PTD-DBM drops on weekdays and performs micro needling weekly.

The conversation discusses using USB microscopes for scalp photos and provides a link to an overview of trichoscopy. Treatments mentioned include Minoxidil, finasteride, and RU58841.

Epibiotech will offer off-the-shelf allogeneic hair multiplication treatment in South Korea, using dermal papilla cells from donors to grow hair in balding areas. This method is cheaper and less invasive than traditional hair transplants.

A 25-year-old is experiencing chronic telogen effluvium (TE) and androgenetic alopecia (AGA) after surgery, using finasteride, red light therapy, and supplements, and considering oral minoxidil despite heart concerns. They are unsure whether to start minoxidil before or after an upcoming surgery, which may trigger another hair shed.

The conversation is about finding a dermatologist in New York City for dutasteride mesotherapy. Alternatives like micro-needling with personal solutions are also discussed.

The user is starting Dutasteride mesotherapy and seeks advice on whether to apply the solution immediately after microneedling or wait 12-24 hours. They couldn't find instructions for first-timers.

PTD-DBM is being explored for hair regrowth by targeting CXXC5, with clinical trials expected after pre-clinical studies. Users express anticipation and skepticism about its effectiveness.

Tretinoin can irritate seborrheic dermatitis, but using it with a moisturizer on calm skin may help. Parallel Health's skin microbiome testing and phage therapy are suggested for persistent issues.

The conversation is about a user's hair loss treatment regimen, which includes Dutasteride, oral Minoxidil, topical Dutasteride, Minoxidil sulfate, antioxidants, and various supplements. The user is also using a derma stamp and has paused Tretinoin due to a TCA peel recovery.

Dermal incision with verteporfin is being explored as a potential hair loss treatment by dermatologist Melissa Toyos, with promising before-and-after photos shared on social media. The conversation discusses its potential effectiveness compared to other treatments like Minoxidil, Finasteride, and RU58841.